Company facts
- Headquarters
- Greenwood Village, Colorado
- Most recent report
- 8-K, filed May 16, 2024
- Incorporated
- Nevada
- Filings on record
- 316 filings
- On EDGAR
- CIK 1552189
- Fiscal year ends
- December
- Filer status
- Emerging growth company
Financials 8 of 46
News 8 of 122
- 8-K Significant contract May 16, 2024
- 8-K Current report on a material event May 7, 2024
- 8-K Significant contract Mar 7, 2024
- 8-K Significant contract Feb 5, 2024
- 8-K/A Acquisition or disposal closed Dec 8, 2023
- 8-K Significant contract Oct 5, 2023
- 8-K Significant contract Oct 2, 2023
- 8-K Significant contract Jul 10, 2023
Prospectuses and Registrations 8 of 14
- S-1 Registration statement for an offering Dec 31, 2019
- S-8 Registration statement for an employee plan Dec 26, 2018
- S-1 Registration statement for an offering Sep 11, 2017
- 424B3 Prospectus supplement for an offering Mar 30, 2016
- 424B4 Final prospectus for an offering Jul 6, 2015
- S-1/A Registration statement for an offering, amended Jun 22, 2015
- S-1/A Registration statement for an offering, amended Jun 12, 2015
- S-1/A Registration statement for an offering, amended May 15, 2015
Ownership 8 of 79
- 4 Insider reported a trade Sep 20, 2023
- SC 13D Large holder reported an active stake Jun 23, 2023
- 4 Insider reported a trade Jun 12, 2023
- 4 Insider reported a trade May 23, 2023
- 4 Insider reported a trade May 9, 2023
- 4 Insider reported a trade Apr 26, 2023
- 4 Insider reported a trade Apr 6, 2023
- 4 Insider reported a trade Mar 1, 2023
Other 8 of 55
- SEC STAFF ACTION May 9, 2025
- 15-12G Jul 16, 2024
- 1-A Jun 11, 2024
- NT 10-Q Notice that a quarterly report will be late Aug 15, 2023
- UPLOAD Comment letter from SEC staff Jul 8, 2022
- CORRESP Reply to SEC staff Jun 27, 2022
- UPLOAD Comment letter from SEC staff May 27, 2022
- CORRESP Reply to SEC staff May 17, 2022
Everything here comes from Panacea Life Sciences Holdings, Inc.'s own filings on SEC EDGAR. The filing list is rechecked every hour.